Also, Georgetown holds an issued US patent on related technology for the use of nilotinib for the treatment of certain neurodegenerative diseases and has other pending patent applications in US and foreign jurisdictions. (sciencedaily.com)
Moussa is an inventor on a Georgetown University patent application for use of nilotinib for the treatment of neurodegenerative disease. (gumc.georgetown.edu)
GUMC says its researchers are now planning larger clinical trials with nilotinib for patients with Parkinson's and other similar diseases including Alzheimer's disease, likely to begin in 2016. (fortune.com)